Director/PDMR Shareholding
Stephen West, a Non-Executive Director of Coiled Therapeutics plc, has purchased 531,743 ordinary shares for a total consideration of £40,016.77, with an average price of 7.52 pence per share. This transaction increases his total shareholding to 2,700,368 ordinary shares, representing 0.63% of the company's issued capital. The purchase occurred on the London Stock Exchange's AIM market on 28 September 2026.
Select text to share a quote on X · sign in to keep highlights & notes in your COIL notes
Coiled Therapeutics (AIM: COIL / OTCQB: COTXF), the clinical-stage precision oncology company developing differentiated small molecule therapies for genetically defined cancers, advises that Stephen West, Non-Executive Director, has today purchased ordinary shares of £0.01 each in the Company ("Ordinary Shares"), as detailed below:
| Number of Ordinary Shares Acquired | Average Price Paid per Ordinary Share | Total Consideration Paid (including charges) | Number of Ordinary Shares Now Held | % of Company's Issued Capital |
|---|---|---|---|---|
| 531,743 | 7.52 pence | £40,016.77 | 2,700,368 | 0.63% |
Regulatory Information
About AO-252
For more information, please visit: www.coiledplc.com and follow us on LinkedIn.
The notification below, made in accordance with the requirements of the UK MAR, provides further detail:
| 1 | Details of the person discharging managerial responsibilities / person closely associated | ||
| a) | Name | Stephen West | |
| 2 | Reason for the notification | ||
| a) | Position/status | Non-Executive Director | |
| b) | Initial notification /Amendment | Initial | |
| a) | Name | Coiled Therapeutics plc | |
| b) | LEI | 254900P4SISIWOR9RH34 | |
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of £0.01 par value ISIN: GB00BSHRN331 | |
| b) | Nature of the transaction | Purchase of 531,743 Ordinary Shares | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| 7.399 pence per share | 270,306 | ||
| 7.650 pence per share | 261,437 | ||
| d | Aggregated information - Aggregated volume - Price | - 531,743 - 7.52p | |
| e) | Date of the transactions | 28 September 2026 | |
| f) | Place of the transactions | London Stock Exchange (XLON); AIM |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.